ATCC’s Institutional Biosafety Committee (IBC)

Welcome to ATCC’s Institutional Biosafety Committee (IBC) Meeting Minutes page, prepared in alignment with the latest NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. ATCC has an IBC to promote transparency and public access. On this page, you can easily find approved meeting minutes and our current IBC roster. 

The IBC reviews new protocols throughout the year and meets semi-annually or as needed to uphold the highest standards of safety and compliance. The IBC advises our internal team on managing biohazards and safeguards the interests of both public health and the environment. Our goal is to support responsible research, build public trust, and ensure regulatory compliance.

Approved minutes posted after approval with redactions.

• 18 December 2025

Name	Role*
Heather Couch, Ph.D.	IBC Chair, IBC Contact
Brian Leroux	Biological Safety Officer, BSO
K. K., Ph.D.	Expert recombinant or synthetic nucleic acid molecule research
L. P., Ph.D.	Expert recombinant or synthetic nucleic acid molecule research
W.S., Ph.D.	Expert recombinant or synthetic nucleic acid molecule research
S-O. S, Ph.D.	Expert recombinant or synthetic nucleic acid molecule research
A.C., LATg	Expert animal containment principles
M.R. Ph.D.	Expert recombinant or synthetic nucleic acid molecule research
J.A., Ph.D.	External
D.B.	External

* ATCC does not engage in research involving plants, thus the ATCC IBC does not include an individual with expertise in plant, plant pathogen, or plant pest containment principles.

Email: [email protected]